Aidigong Announces Executive Changes and Financial Review
Aidigong Maternal & Child Health (HK:0286) has announced the appointment of Ms. Wang Aier as the new legal representative of its subsidiary, Shenzhen Aidigong, replacing Ms. Zhu Yufei, who remains the general manager of the postpartum business. An independent third party will conduct a financial review of Shenzhen Aidigong to improve operational management and corporate governance. The board assures that these changes will not impact the Group’s overall operations.
Aidigong Maternal & Child Health (HK:0286) has released an update.
Aidigong Maternal & Child Health Limited has announced the appointment of Ms. Wang Aier as the new legal representative of its subsidiary, Shenzhen Aidigong, replacing Ms. Zhu Yufei, who will continue as general manager of the postpartum business. Additionally, a financial review of Shenzhen Aidigong will be conducted by an independent third party to enhance the subsidiary’s operational management and corporate governance. The Company’s board assures that these changes will not affect the Group’s overall operations.
For further insights into HK:0286 stock, check out TipRanks’ Stock Analysis page.